Beam Therapeutics Inc. (BEAM) Social Stream



Beam Therapeutics Inc. (BEAM): $30.67

-1.73 (-5.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BEAM to Watchlist
Sign Up

Industry: Biotech


Ranked

of 385

in industry

BEAM THERAPEUTICS INC (BEAM) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering BEAM THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 10 $150 $85 $124.333 $32.4 283.74%
2021-12-22 10 $150 $85 $121.555 $32.4 275.17%
2022-01-05 11 $150 $85 $122.4 $32.4 277.78%
2022-01-10 11 $159 $85 $124.5 $32.4 284.26%
2022-02-01 9 $159 $85 $122.222 $32.4 277.23%
2022-02-28 10 $159 $85 $126.25 $32.4 289.66%
2022-03-01 9 $154 $110 $130.285 $32.4 302.11%
2022-05-09 8 $154 $110 $130.285 $32.4 302.11%
2022-05-10 8 $154 $75 $114.142 $32.4 252.29%
2022-05-11 8 $130 $75 $110 $32.4 239.51%
2022-06-08 8 $130 $75 $103.142 $32.4 218.34%
2022-06-17 9 $130 $41 $95.375 $32.4 194.37%
2022-07-18 9 $130 $61 $97.875 $32.4 202.08%
2022-08-10 10 $130 $61 $97.875 $32.4 202.08%
2022-09-17 10 $130 $60 $90.125 $32.4 178.16%
2022-11-07 10 $130 $60 $89.222 $32.4 175.38%
2022-11-08 11 $130 $60 $84.666 $32.4 161.31%
2022-12-13 11 $130 $60 $82.4 $32.4 154.32%
2022-12-20 11 $130 $60 $82.9 $32.4 155.86%
2023-01-06 10 $103 $60 $77.222 $32.4 138.34%
2023-01-26 10 $103 $60 $76.777 $32.4 136.97%
2023-02-01 11 $103 $60 $75.3 $32.4 132.41%
2023-02-08 11 $103 $60 $74.3 $32.4 129.32%
2023-03-01 12 $103 $60 $74.1 $32.4 128.7%
2023-03-02 12 $105 $60 $74.727 $32.4 130.64%

The Trend in the Analyst Price Target


BEAM's average price target has moved down $44.44 over the prior 18 months.

BEAM reports an average of 108.73% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-07-18 9 130 61 97.875 58.01 68.72%
2022-12-13 11 130 60 82.400 45.74 80.15%
2023-01-26 10 103 60 76.777 43.85 75.09%
2023-02-01 11 103 60 75.300 45.97 63.8%
2023-03-02 12 105 60 74.727 38.81 92.55%

BEAM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 10 0 2 0 0 12

The Trend in the Broker Recommendations


Over the past 22 months, BEAM's average broker recommendation rating improved by 0.79.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, BEAM THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2939.81% of them.
  • BEAM has a greater average analyst price target than 3000.34% of stocks in the mid market cap category.
  • BEAM THERAPEUTICS INC's number of analysts covering the stock is higher than 2638.04% of stocks in the mid market cap category.
  • In terms of how BEAM THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -2259.44% of that group.

Stocks similar to BEAM THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VIR, SWTX, and IMVT.

Is BEAM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5923 seconds.